AustralieFrV1, Main, Exploration, bibRecordById, pubmed:28961850

Changes in the use of end points in clinical trials for elderly cancer patients over time.

Identifieur interne : 001018 ( Main/Exploration ); précédent : 001017; suivant : 001019

Changes in the use of end points in clinical trials for elderly cancer patients over time.

Auteurs : O. Le Saux ; C. Falandry ; H K Gan ; B. You ; G. Freyer ; J. Péron

Source :

Annals of oncology : official journal of the European Society for Medical Oncology [ 1569-8041 ] ; 2017.

RBID : pubmed:28961850

Abstract

Physicians need well-addressed clinical trials assessing benefits and harm of treatments to avoid under-treatment or over-treatment of elderly patients. The main objectives of this report were to present an overview of end points used in clinical trials dedicated to elderly patients; and to assess the evolution in chosen end points before and after the creation of the International Society of Geriatric Oncology in the early 2000s.

DOI: 10.1093/annonc/mdx354
PubMed: 28961850

Affiliations:

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Changes in the use of end points in clinical trials for elderly cancer patients over time.</title>
<author><name sortKey="Le Saux, O" sort="Le Saux, O" uniqKey="Le Saux O" first="O" last="Le Saux">O. Le Saux</name>
<affiliation><nlm:affiliation>Medical Oncology Department, Institut de Cancérologie des Hospices Civils de Lyon (IC-HCL), Pierre-Bénite.</nlm:affiliation>
<wicri:noCountry code="subField">Pierre-Bénite</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Falandry, C" sort="Falandry, C" uniqKey="Falandry C" first="C" last="Falandry">C. Falandry</name>
<affiliation><nlm:affiliation>Geriatric Oncology Department, Centre Hospitalier Lyon Sud, Pierre-Bénite.</nlm:affiliation>
<wicri:noCountry code="subField">Pierre-Bénite</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Gan, H K" sort="Gan, H K" uniqKey="Gan H" first="H K" last="Gan">H K Gan</name>
<affiliation><nlm:affiliation>Olivia Newton-John Cancer Research Institute, Heidelberg.</nlm:affiliation>
<wicri:noCountry code="subField">Heidelberg</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="You, B" sort="You, B" uniqKey="You B" first="B" last="You">B. You</name>
<affiliation><nlm:affiliation>Medical Oncology Department, Institut de Cancérologie des Hospices Civils de Lyon (IC-HCL), Pierre-Bénite.</nlm:affiliation>
<wicri:noCountry code="subField">Pierre-Bénite</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Freyer, G" sort="Freyer, G" uniqKey="Freyer G" first="G" last="Freyer">G. Freyer</name>
<affiliation><nlm:affiliation>Medical Oncology Department, Institut de Cancérologie des Hospices Civils de Lyon (IC-HCL), Pierre-Bénite.</nlm:affiliation>
<wicri:noCountry code="subField">Pierre-Bénite</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Peron, J" sort="Peron, J" uniqKey="Peron J" first="J" last="Péron">J. Péron</name>
<affiliation><nlm:affiliation>Medical Oncology Department, Institut de Cancérologie des Hospices Civils de Lyon (IC-HCL), Pierre-Bénite.</nlm:affiliation>
<wicri:noCountry code="subField">Pierre-Bénite</wicri:noCountry>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:28961850</idno>
<idno type="pmid">28961850</idno>
<idno type="doi">10.1093/annonc/mdx354</idno>
<idno type="wicri:Area/PubMed/Corpus">000277</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000277</idno>
<idno type="wicri:Area/PubMed/Curation">000275</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000275</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000275</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000275</idno>
<idno type="wicri:Area/Ncbi/Merge">004F58</idno>
<idno type="wicri:Area/Ncbi/Curation">004F58</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004F58</idno>
<idno type="wicri:Area/Main/Merge">001013</idno>
<idno type="wicri:Area/Main/Curation">001018</idno>
<idno type="wicri:Area/Main/Exploration">001018</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Changes in the use of end points in clinical trials for elderly cancer patients over time.</title>
<author><name sortKey="Le Saux, O" sort="Le Saux, O" uniqKey="Le Saux O" first="O" last="Le Saux">O. Le Saux</name>
<affiliation><nlm:affiliation>Medical Oncology Department, Institut de Cancérologie des Hospices Civils de Lyon (IC-HCL), Pierre-Bénite.</nlm:affiliation>
<wicri:noCountry code="subField">Pierre-Bénite</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Falandry, C" sort="Falandry, C" uniqKey="Falandry C" first="C" last="Falandry">C. Falandry</name>
<affiliation><nlm:affiliation>Geriatric Oncology Department, Centre Hospitalier Lyon Sud, Pierre-Bénite.</nlm:affiliation>
<wicri:noCountry code="subField">Pierre-Bénite</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Gan, H K" sort="Gan, H K" uniqKey="Gan H" first="H K" last="Gan">H K Gan</name>
<affiliation><nlm:affiliation>Olivia Newton-John Cancer Research Institute, Heidelberg.</nlm:affiliation>
<wicri:noCountry code="subField">Heidelberg</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="You, B" sort="You, B" uniqKey="You B" first="B" last="You">B. You</name>
<affiliation><nlm:affiliation>Medical Oncology Department, Institut de Cancérologie des Hospices Civils de Lyon (IC-HCL), Pierre-Bénite.</nlm:affiliation>
<wicri:noCountry code="subField">Pierre-Bénite</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Freyer, G" sort="Freyer, G" uniqKey="Freyer G" first="G" last="Freyer">G. Freyer</name>
<affiliation><nlm:affiliation>Medical Oncology Department, Institut de Cancérologie des Hospices Civils de Lyon (IC-HCL), Pierre-Bénite.</nlm:affiliation>
<wicri:noCountry code="subField">Pierre-Bénite</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Peron, J" sort="Peron, J" uniqKey="Peron J" first="J" last="Péron">J. Péron</name>
<affiliation><nlm:affiliation>Medical Oncology Department, Institut de Cancérologie des Hospices Civils de Lyon (IC-HCL), Pierre-Bénite.</nlm:affiliation>
<wicri:noCountry code="subField">Pierre-Bénite</wicri:noCountry>
</affiliation>
</author>
</analytic>
<series><title level="j">Annals of oncology : official journal of the European Society for Medical Oncology</title>
<idno type="eISSN">1569-8041</idno>
<imprint><date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Physicians need well-addressed clinical trials assessing benefits and harm of treatments to avoid under-treatment or over-treatment of elderly patients. The main objectives of this report were to present an overview of end points used in clinical trials dedicated to elderly patients; and to assess the evolution in chosen end points before and after the creation of the International Society of Geriatric Oncology in the early 2000s.</div>
</front>
</TEI>
<affiliations><list></list>
<tree><noCountry><name sortKey="Falandry, C" sort="Falandry, C" uniqKey="Falandry C" first="C" last="Falandry">C. Falandry</name>
<name sortKey="Freyer, G" sort="Freyer, G" uniqKey="Freyer G" first="G" last="Freyer">G. Freyer</name>
<name sortKey="Gan, H K" sort="Gan, H K" uniqKey="Gan H" first="H K" last="Gan">H K Gan</name>
<name sortKey="Le Saux, O" sort="Le Saux, O" uniqKey="Le Saux O" first="O" last="Le Saux">O. Le Saux</name>
<name sortKey="Peron, J" sort="Peron, J" uniqKey="Peron J" first="J" last="Péron">J. Péron</name>
<name sortKey="You, B" sort="You, B" uniqKey="You B" first="B" last="You">B. You</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001018 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001018 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:28961850
   |texte=   Changes in the use of end points in clinical trials for elderly cancer patients over time.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:28961850" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

Serveur d'exploration sur les relations entre la France et l'Australie

Changes in the use of end points in clinical trials for elderly cancer patients over time.

Changes in the use of end points in clinical trials for elderly cancer patients over time.

Source :

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.